Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in:

05.11.2024 | DFP-Fortbildung

Surgical therapy of rectal cancer

verfasst von: Katharina Esswein, MD, Elisabeth Gasser, MD, Marijana Ninkovic, MD, Stefan Scheidl, MD, Dr. Alexander Perathoner, MD, Prim. Prof.

Erschienen in: European Surgery | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Summary

Radical rectal resection is a crucial element in the multimodal treatment of rectal cancer. Tumor stage, tumor location, and patient characteristics are critical for selecting resection procedures. Therefore, an exact preoperative diagnostic workup is essential. Postoperative complications, such as anastomotic insufficiency or low anterior resection syndrome (LARS), may impact the oncological outcome and quality of life. In some cases, a clinical complete response (cCR) can be achieved by multimodal treatment (e.g., total neoadjuvant treatment, TNT). These patients can be included in a watch-and-wait strategy without resection.
Vorheriger Artikel Perforated small bowel diverticular disease: a case report to raise awareness for surgical treatment in complicated jejunal diverticulitis
Literatur
1.
Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–iv40.CrossRefPubMed
2.
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Kolorektales Karzinom. Langversion ed. Vol. 2.1. 2019. AWMF Registrierungsnummer: 021/007OL2019.
3.
Österreichische Gesellschaft für Chirurgische Onkologie, der Chirurgischen Krebstherapie M. Krause & Pachernegg GmbH. WIRTSCHAFT: VERLAG für MEDIZIN und; 2011. p. 356.
4.
Body A, Prenen H, Lam M, Davies A, Tipping-Smith S, Lum C, et al. Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges. Clin Colorectal Cancer. 2021;20(1):29–41.CrossRefPubMed
5.
Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42.CrossRefPubMed
6.
Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702–15.CrossRefPubMed
7.
Habr-Gama A, Perez RO. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg. 2009;96(2):125–7.CrossRefPubMed
8.
Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol.2022:JCO2200032.
9.
Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres. Eur J Surg Oncol. 2017;43(1:107–17.CrossRef
10.
11.
Marco S. Referenz Allgemein- und Viszeralchirurgie – Unterer Gastrointestinaltrakt. 2022.
12.
Holmer C. Sphinktererhaltende Operationen beim Rektumkarzinom. In: Kreis ME, Asbach P, editors. MRT-basierte Chirurgie des Rektumkarzinoms. Berlin, Heidelberg: Springer Berlin Heidelberg; 2020. pp. 109–14.CrossRef
13.
Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251(5):807–18.CrossRefPubMed
14.
Kienle P, Magdeburg JR. Chronic anastomotic leak after low rectal resection—an unsolved problem? Chirurg. 2021;92(7):605–11.CrossRefPubMed
15.
Wu SW, Ma CC, Yang Y. Role of protective stoma in low anterior resection for rectal cancer: a meta-analysis. World J Gastroenterol. 2014;20(47):18031–7.CrossRefPubMedPubMedCentral
16.
Sharp G, Steffens D, Koh CE. Evidence of negative pressure therapy for anastomotic leak: a systematic review. ANZ J Surg. 2021;91(4):537–45.CrossRefPubMed
17.
Kreis M, Straßburg J. Moderne Chirurgie des Rektumkarzinoms. Veralg: Springer; 2015.CrossRef
18.
Keane C, Fearnhead NS, Bordeianou LG, Christensen P, Basany EE, Laurberg S, et al. International Consensus Definition of Low Anterior Resection Syndrome. Dis Colon Rectum. 2020;63(3):274–84.CrossRefPubMedPubMedCentral
19.
Emmertsen KJ, Laurberg S, Group RCFS.. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013;100(10):1377–87.CrossRefPubMed
20.
Erlandsson J, Lörinc E, Ahlberg M, Pettersson D, Holm T, Glimelius B, et al. Tumor regression after radiotherapy for rectal cancer—Results from the randomised Stockholm III trial. Radiother Oncol. 2019;135:178–86.CrossRefPubMed
21.
van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–45.CrossRefPubMed
Metadaten
Titel
Surgical therapy of rectal cancer
verfasst von
Katharina Esswein, MD
Elisabeth Gasser, MD
Marijana Ninkovic, MD
Stefan Scheidl, MD
Dr. Alexander Perathoner, MD, Prim. Prof.
Publikationsdatum
05.11.2024
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 1/2025
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-024-00837-y

Weitere Artikel der Ausgabe 1/2025

Chronic kidney disease is associated with increased 30-day mortality and morbidities after esophagectomy: a propensity score matched study

  • original article

Thoracic surgeons have better outcome profiles following esophagectomy: an ACS-NSQIP study

  • original article

Surgical training in transition—quality over quantity?

  • editorial

Perforated small bowel diverticular disease: a case report to raise awareness for surgical treatment in complicated jejunal diverticulitis

  • case report

Heading for new shores

  • editorial

Surgeon perspectives on factors affecting intraoperative complexity in major emergency abdominal surgery: a Danish nationwide survey

  • Open Access
  • original article